We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Two leading experts have been appointed as members of the Advisory Council on the Misuse of Drugs.
The Advisory Council on the Misuse of Drugs (ACMD) has today (28 January 2026) published its updated harms assessment of ketamine.
Professor Wood will replace Owen Bowden-Jones as chair on 1 January 2026.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about zuranolone.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about 3 growth hormone agonists.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about the consideration of ganaxolone.
Government response to the ACMD's report on the consideration of barriers to research: part 2.
Letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD) discussing the ACMD work programme for 2025.
Four more experts have been appointed members to the Advisory Council on the Misuse of Drugs.
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to conduct an updated harms assessment of ketamine.
Ten leading experts have joined the Advisory Council on the Misuse of Drugs (ACMD) to strengthen its vital work advising the government on drug harms.
The Advisory Council on the Misuse of Drugs responds to the government on their proposal to amend the licensing regimen for industrial hemp.
The government responds to the ACMD's report on recently encountered novel benzodiazepines and related compounds.
First published during the 2022 to 2024 Sunak Conservative government
Government response to the report by the Advisory Council on the Misuse of Drugs on acyl piperazine opioids, including 2-methyl-AP-237.
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to review the fees applicable under the hemp licensing regime.
ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Government response to the report by the Advisory Council on the Misuse of Drugs on xylazine, medetomidine and detomidine.
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding NHS England proposals on electronic prescribing.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).